Journal of Cancer Therapy

Vol.9 No.3(2018), Paper ID 82839, 9 pages

DOI:10.4236/jct.2018.93018

 

Sustained Remission with Mogamulizumab in Peripheral T Cell Lymphoma with Aberrant CD20 Expression: Case Report and Literature Review

 

Kentaro Fukushima, Hiroshi Sata, Masami Imakita, Takahiro Karasuno

 

Department of Hematology, Rinku General Medical Center, Izumisano, Osaka, Japan
Department of Hematology, Rinku General Medical Center, Izumisano, Osaka, Japan
Department of Pathology, Rinku General Medical Center, Izumisano, Osaka, Japan
Department of Hematology, Rinku General Medical Center, Izumisano, Osaka, Japan

 

Copyright © 2018 Kentaro Fukushima, Hiroshi Sata, Masami Imakita, Takahiro Karasuno et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Fukushima, K. , Sata, H. , Imakita, M. and Karasuno, T. (2018) Sustained Remission with Mogamulizumab in Peripheral T Cell Lymphoma with Aberrant CD20 Expression: Case Report and Literature Review. Journal of Cancer Therapy, 9, 179-187. doi: 10.4236/jct.2018.93018.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.